Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000052

Director bought 259,259 shares at $13.50 ($3,499,997)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Slingsby Brian Taylor Director 2025-03-13 Purchase +259,259 $13.50 $3,499,997 8,903,838 I
Open-market purchases · 259,259 sh · avg $13.50 · $3,499,997
Loading xslF345X05/wk-form4_1745622111.xml…